| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.33T | 8.60T | 7.86T | 4.89T | 2.84T | 2.89T |
| Gross Profit | 3.85T | 3.59T | 2.86T | 2.58T | 2.28T | 2.26T |
| EBITDA | 1.35T | 1.40T | 1.13T | 945.90B | 769.51B | 819.14B |
| Net Income | 1.05T | 885.43B | 678.99B | 555.53B | 530.48B | 471.02B |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 91.33T | 83.48T | 72.97T | 67.15T | 51.36T | 74.42T |
| Total Debt | 64.42T | 60.89T | 58.95T | 45.34T | 40.96T | 40.31T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 11.18T | 10.44T | 10.23T | 9.13T | 9.08T | 9.26T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.17T | 1.63T | 8.68T | 4.78T | 16.40T |
| Operating Cash Flow | 0.00 | -3.82T | 1.88T | 8.87T | 4.92T | 16.61T |
| Investing Cash Flow | 0.00 | 3.79T | 1.98T | 6.61T | -1.86T | -9.76T |
| Financing Cash Flow | 0.00 | -299.03B | -230.99B | -611.14B | -522.06B | 40.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $95.99B | 9.08 | 21.64% | 9.77% | 22.96% | 6.95% | |
74 Outperform | $87.95B | 10.39 | 12.22% | 3.77% | 3.87% | 18.20% | |
73 Outperform | $95.40B | 14.67 | 15.75% | 0.85% | 1.39% | 0.34% | |
71 Outperform | $89.95B | 12.15 | 11.98% | 3.11% | 3.51% | 21.52% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $79.20B | 12.62 | 9.93% | 3.19% | -15.15% | 29.78% | |
57 Neutral | $104.30B | 10.79 | 9.73% | 2.31% | -8.02% | 22.45% |